Coldstream Capital Management Inc Pacira Bio Sciences, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,585 shares of PCRX stock, worth $40,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,585Holding current value
$40,908% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
264Shares Held
48.7MCall Options Held
853KPut Options Held
184K-
Black Rock Inc. New York, NY8.01MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$135 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57.8 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.18B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...